1. Home
  2. DVA vs SEIC Comparison

DVA vs SEIC Comparison

Compare DVA & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • SEIC
  • Stock Information
  • Founded
  • DVA 1994
  • SEIC 1968
  • Country
  • DVA United States
  • SEIC United States
  • Employees
  • DVA N/A
  • SEIC N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • SEIC Investment Bankers/Brokers/Service
  • Sector
  • DVA Health Care
  • SEIC Finance
  • Exchange
  • DVA Nasdaq
  • SEIC Nasdaq
  • Market Cap
  • DVA 10.9B
  • SEIC 9.7B
  • IPO Year
  • DVA 1995
  • SEIC N/A
  • Fundamental
  • Price
  • DVA $136.18
  • SEIC $85.26
  • Analyst Decision
  • DVA Hold
  • SEIC Buy
  • Analyst Count
  • DVA 4
  • SEIC 5
  • Target Price
  • DVA $157.00
  • SEIC $87.60
  • AVG Volume (30 Days)
  • DVA 828.5K
  • SEIC 1.2M
  • Earning Date
  • DVA 05-12-2025
  • SEIC 07-23-2025
  • Dividend Yield
  • DVA N/A
  • SEIC 1.11%
  • EPS Growth
  • DVA 14.90
  • SEIC 25.40
  • EPS
  • DVA 10.11
  • SEIC 4.59
  • Revenue
  • DVA $12,968,524,000.00
  • SEIC $2,164,916,000.00
  • Revenue This Year
  • DVA $6.00
  • SEIC $6.11
  • Revenue Next Year
  • DVA $3.66
  • SEIC $4.57
  • P/E Ratio
  • DVA $13.48
  • SEIC $18.57
  • Revenue Growth
  • DVA 5.11
  • SEIC 10.33
  • 52 Week Low
  • DVA $131.76
  • SEIC $62.38
  • 52 Week High
  • DVA $179.60
  • SEIC $87.25
  • Technical
  • Relative Strength Index (RSI)
  • DVA 37.73
  • SEIC 63.52
  • Support Level
  • DVA $136.50
  • SEIC $83.29
  • Resistance Level
  • DVA $140.42
  • SEIC $86.34
  • Average True Range (ATR)
  • DVA 3.66
  • SEIC 1.50
  • MACD
  • DVA -0.59
  • SEIC -0.14
  • Stochastic Oscillator
  • DVA 11.71
  • SEIC 69.23

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About SEIC SEI Investments Company

SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.

Share on Social Networks: